DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01485952 (ClinicalTrials.gov)	March 2011	29/11/2011	An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196	An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients to Assess Pharmacokinetics, Candidate Pharmacodynamic Measures of Target Engagement and Disease Modulation as Well as Acute Phenotypical Effects Following Multiple Oral Doses of SEN0014196.	Huntington Disease	Drug: SEN0014196 (Low Dose);Drug: SEN0014196 (High Dose);Drug: Placebo	Siena Biotech S.p.A.	Seventh Framework Programme;European Huntington's Disease Network	Completed	18 Years	70 Years	Both	55	Phase 1	Germany

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01485952
(ClinicalTrials.gov)

March 2011

29/11/2011

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients to Assess Pharmacokinetics, Candidate Pharmacodynamic Measures of Target Engagement and Disease Modulation as Well as Acute Phenotypical Effects Following Multiple Oral Doses of SEN0014196.

Huntington Disease

Drug: SEN0014196 (Low Dose);Drug: SEN0014196 (High Dose);Drug: Placebo

Siena Biotech S.p.A.

Seventh Framework Programme;European Huntington's Disease Network

Completed

18 Years

70 Years

Both

Phase 1

Germany